Each filer's latest filing for 045396108 since 12/18/2024, largest first.
| Filer | % of Class | Filed |
|---|---|---|
| Gilead Sciences, Inc. 13D/A | 25.1% |
5/27/2026
Event 5/22/2026
|
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2023 Q4 | 46 | 8.65 M | $7.09M |
| 2023 Q3 | 33 | 9.54 M | $8.44M |
| 2023 Q2 | 33 | 10.5 M | $12.0M |
| 2023 Q1 | 39 | 12.1 M | $10.1M |
| 2022 Q4 | 41 | 14.2 M | $18.4M |
| 2022 Q3 | 51 | 16.6 M | $27.2M |
| 2022 Q2 | 55 | 17.2 M | $36.1M |
| 2022 Q1 | 55 | 19.1 M | $39.3M |
| 2021 Q4 | 63 | 23.1 M | $53.8M |
| 2021 Q3 | 66 | 22.7 M | $79.0M |
| 2021 Q2 | 94 | 27.1 M | $105M |
| 2021 Q1 | 109 | 28.7 M | $134M |
| 2020 Q4 | 112 | 27.1 M | $164M |
| 2020 Q3 | 121 | 30.5 M | $502M |
| 2020 Q2 | 108 | 30.0 M | $700M |
| 2020 Q1 | 100 | 29.0 M | $430M |
| 2019 Q4 | 104 | 28.1 M | $576M |
| 2019 Q3 | 99 | 20.7 M | $204M |
| 2019 Q2 | 108 | 21.2 M | $288M |
| 2019 Q1 | 107 | 22.1 M | $435M |
| 2018 Q4 | 108 | 21.4 M | $483M |
| 2018 Q3 | 115 | 21.7 M | $803M |
| 2018 Q2 | 105 | 16.7 M | $654M |
| 2018 Q1 | 109 | 16.1 M | $789M |
| 2017 Q4 | 100 | 15.6 M | $704M |
| 2017 Q3 | 72 | 12.4 M | $432M |
| 2017 Q2 | 66 | 12.5 M | $259M |
| 2017 Q1 | 49 | 11.9 M | $301M |
| 2016 Q4 | 37 | 11.7 M | $140M |
| 2016 Q3 | 36 | 11.1 M | $79.4M |
| 2016 Q2 | 44 | 11.3 M | $61.9M |
| 2016 Q1 | 47 | 12.4 M | $61.6M |
| 2015 Q4 | 49 | 12.3 M | $92.3M |
| 2015 Q3 | 53 | 12.4 M | $118M |
| 2015 Q2 | 58 | 12.1 M | $232M |
| 2015 Q1 | 34 | 10.8 M | $143M |
| 2014 Q4 | 24 | 4.30 M | $33.5M |
| 2014 Q3 | 22 | 1.66 M | $14.1M |